supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 4 years ago
Research Papers that Mention the Interaction
“Conclusions This study demonstrates that splitting intake moments of pazopanib leads to a 79% increase in C min , with acceptable tolerability.”
Cost-Neutral Optimization of Pazopanib Exposure by Splitting Intake Moments: A Prospective Pharmacokinetic Study in Cancer Patients“ABSTRACT Aim: Pazopanib is a multi-targeted tyrosine kinase inhibitor, blocking VEGF-A, B, C and FGF pathways and might suppress tumor angiogenesis and growth in HNSCC.”
1003PBLEEDING COMPLICATIONS AND POSSIBLE RESISTANCE PATTERNS OF ANTI-ANGIOGENESIS TREATMENTS IN RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA(R/M HNSCC) - REFLECTIONS FROM A PHASE II STUDY OF PAZOPANIB IN R/M HNSCC.
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback